Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
Title
Created Date
Apoptosis induction of POS canine osteosarcoma cells by vitamin D and retinoids
14 July 2017
1,25-Dihydroxyvitamin D3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line
11 July 2017
1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1)
06 July 2017
1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells
05 July 2017
1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production
04 July 2017
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3
27 June 2017
1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1
21 June 2017
1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells
21 June 2017
Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors
16 June 2017
A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours
15 June 2017
Display #
5
10
15
20
25
30
50
100
All
Page 34 of 60
Start
Prev
29
30
31
32
33
34
35
36
37
38
Next
End
Search
Follow us...
Latest
Melatonin as a Potential Multitherapeutic Agent
Ionizing Radiation as a Source of Oxidative Stress-The Protective Role of Melatonin and Vitamin D
Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
Melatonin and its ubiquitous anticancer effects
Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
The impact of vitamin D on cancer: A mini review
Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
Somatostatin and Somatostatin Receptors in Tumour Biology
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
How effective is chemo therapy?
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Vademecum
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer